Conceptual model and experimental strategy of the project.
This project aims to characterize the compensatory mechanisms associated with the loss of ARB2A that contribute to maintaining neurodevelopment and to determine how their progressive failure with age may promote neurodegeneration. (1) Phenotypes of Arb2a KO/KO and wild-type mice are characterized at 4, 6, and 8 months using behavioral tests (open field, rotarod, and wire-hang), histological analyses, and immunofluorescence. (2) Compensatory pathways are identified using RNA-seq and targeted proteomic analysis of stress-response markers, including the ISR and UPR pathways. (3) Candidate mechanisms are subsequently inhibited or activated in primary cerebellar cultures to assess their causal effects on behavioral, histological, and cellular phenotypes. This approach will help clarify the protective role of ARB2A compensatory mechanisms in neurodevelopment, in relation to CHARGE syndrome, and in ALS-like neurodegeneration.
Project description
Narjiss Messy1, Sanaa Tork1, Ouliana Souchkova1, Nicolas Pilon1
1Laboratoire de génétique moléculaire du développement, Département des sciences biologiques, Université du Québec à Montréal, Montréal, Canada.
ARB2A is a conserved protein involved in transcriptional regulation and alternative splicing. Hypomorphic mutations in Arb2a are associated with CHARGE syndrome, whereas its complete loss in Arb2aKO/KO mice results in a motor phenotype in adulthood consistent with amyotrophic lateral sclerosis (ALS). We hypothesize that, in Arb2aKO/KO mice, compensatory mechanisms prevent the neurodevelopmental abnormalities associated with CHARGE syndrome, but become insufficient with age, promoting neurodegeneration and an ALS-like phenotype. This project aims to characterize these mechanisms and their protective role. Arb2aKO/KO and wildtype mice will be studied at 4, 6, and 8 months of age using behavioral, histological and cellular analyses. The compensatory mechanisms will be identified via RNA-seq and targeted proteomic analysis of stress response pathways. Candidate mechanisms will then be pharmacologically manipulated to assess their causal role. Preliminary results show that 8-month-old Arb2aKO/KO mice exhibit hypoactivity, impaired coordination and balance, as well as abnormalities in Purkinje cells. This project aligns with the mission of CERMO-FC by contributing to a better understanding of the cellular and molecular mechanisms underlying rare diseases of the nervous system and to the identification of compensatory mechanism that could inform therapeutic strategies.
Research team
Name: Narjiss Messy
Supervisor: Nicolas Pilon
Recipient: CEMO-FC Doctoral Scholarship 2026

